title: Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
abstract: The tyrosine kinase c-Abl is implicated in a variety of cellular processes that are tightly regulated by c-Abl kinase activity and/or by interactions between c-Abl and other signaling molecules. The interaction of c-Abl with the Abl interactor protein Abi2 is shown to be negatively regulated by phosphorylation of serines 637 and 638. These serines are adjacent to the PxxP motif (PTPPKRS637S638SFR) that binds the SH3 domain of Abi. Phosphorylation of the Abl 593-730 fragment by Pak2 dramatically reduces Abi2 binding ( approximately 90%). Mutation of serines 637-639 to alanine (3A) or aspartate (3D) results in an increased tyrosine kinase activity of c-Abl 3D, and a slight reduction of the activity of the 3A mutant, as compared to wild-type (WT) c-Abl. The interaction between Abi2 and c-Abl 3D is inhibited by 80%, as compared to WT c-Abl or c-Abl 3A. This is accompanied by a 2-fold increase in binding of Crk to c-Abl 3D. The data indicate a molecular mechanism whereby phosphorylation of c-Abl by Pak2 inhibits the interaction between the SH3 domain of Abi2 and the PxxP motif of c-Abl. This phosphorylation enhances the association of c-Abl with the substrate Crk and increases c-Abl-mediated phosphorylation of Crk, thus altering the association of Crk with other signaling molecules.
authors.affiliation: Department of Biochemistry, University of California, Riverside, California 92521, USA.
authors.forename: Jin-Hun
authors.initials: JH
authors.lastname: Jung
authors.forename: Ann Marie
authors.initials: AM
authors.lastname: Pendergast
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Zipfel
authors.forename: Jolinda A
authors.initials: JA
authors.lastname: Traugh
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D000255:Adenosine Triphosphate / Q000378:metabolism; D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D002460:Cell Line; D015870:Gene Expression; D006801:Humans; D047468:Immunoprecipitation; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D010748:Phosphopeptides / Q000032:analysis / Q000737:chemistry; D010766:Phosphorylation; D011485:Protein Binding; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D016315:Proto-Oncogene Proteins c-abl / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D050737:Proto-Oncogene Proteins c-crk / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D012694:Serine / Q000378:metabolism; D014162:Transfection; D020764:cdc42 GTP-Binding Protein / Q000235:genetics; D054462:p21-Activated Kinases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
chemical_list: C096831:ABI2 protein, human; D048868:Adaptor Proteins, Signal Transducing; C485285:CRK protein, human; D010748:Phosphopeptides; D050737:Proto-Oncogene Proteins c-crk; D011994:Recombinant Proteins; D012694:Serine; D000255:Adenosine Triphosphate; D011505:Protein-Tyrosine Kinases; D016315:Proto-Oncogene Proteins c-abl; C515907:PAK2 protein, human; D054462:p21-Activated Kinases; D020764:cdc42 GTP-Binding Protein